Vimarsana
Biggest News Aggregation in the World

Page 4 - Us Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Us Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Us Life Sciences Today - Breaking & Trending Today

Deloitte's 12th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Rises to Highest Level Since 2014 - Vimarsana News

Deloitte's 12th Annual Pharmaceutical Innovation Report: Pharma R&D Return on Investment Rises to Highest Level Since 2014

/PRNewswire/ -- Key Takeaways: Projected returns on investment in pharma R&D in 2021 have risen to 7 % from 2.7 %, the largest annual increase since the study...

München: Museum Biotopia soll 2028 eröffnet werden - Vimarsana News

München: Museum Biotopia soll 2028 eröffnet werden

Schloss Nymphenburg: 200 Millionen Euro soll es kosten, die Erwartungen sind hoch: Es soll ein Museum von internationaler Strahlkraft werden.

Mayor briefed on plans by US company to open new HQ in Limerick town - Vimarsana News

Mayor briefed on plans by US company to open new HQ in Limerick town

THE Mayor of the city and county of Limerick has visited the site of a major construction project in Newcastle West. Last month, US Life Sciences firm Orte...

New lab development downtown prepares to grow Worcester's life sciences market - Vimarsana News

New lab development downtown prepares to grow Worcester's life sciences market

New lab development downtown prepares to grow Worcester's life science market

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials - Vimarsana News

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials ADELAIDE, AUS, Apr 29, 2021 - (ACN Newswire) - Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic enablement company advancing improved analytical methods and outcomes for developers of biotherapeutic drugs and diagnostics, shared key ways to navigate the immunogenicity and biomarker requirements for clinical trials via webinar. Watch the webinar here (no registration required): https://bit.ly/3s...